118 related articles for article (PubMed ID: 28780472)
1. Different profiles of the mRNA levels of DNA repair genes in MCF-7 and SH-SY5Y cells after treatment with combination of cisplatin, 50-Hz electromagnetic field and bleomycin.
Sanie-Jahromi F; Saadat M
Biomed Pharmacother; 2017 Oct; 94():564-568. PubMed ID: 28780472
[TBL] [Abstract][Full Text] [Related]
2. Effects of extremely low frequency electromagnetic field and cisplatin on mRNA levels of some DNA repair genes.
Sanie-Jahromi F; Saadat I; Saadat M
Life Sci; 2016 Dec; 166():41-45. PubMed ID: 27721000
[TBL] [Abstract][Full Text] [Related]
3. Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells.
Mahmoudinasab H; Saadat M
DNA Cell Biol; 2018 Apr; 37(4):330-335. PubMed ID: 29446648
[TBL] [Abstract][Full Text] [Related]
4. Effects of electromagnetic field, cisplatin and morphine on cytotoxicity and expression levels of DNA repair genes.
Sanie-Jahromi F; Saadat M
Mol Biol Rep; 2018 Oct; 45(5):807-814. PubMed ID: 29968116
[TBL] [Abstract][Full Text] [Related]
5. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
Brooks SE; Korbut TT; Dupuis NP; Holden SA; Teicher BA
Cancer Chemother Pharmacol; 1995; 36(5):431-8. PubMed ID: 7634385
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line.
Cece R; Barajon I; Tredici G
Anticancer Res; 1995; 15(3):777-82. PubMed ID: 7645958
[TBL] [Abstract][Full Text] [Related]
8. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan S; Smith ML; Rivet DJ; Duba D; Zhan Q; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Apr; 55(8):1649-54. PubMed ID: 7712469
[TBL] [Abstract][Full Text] [Related]
9. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
10. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
11. Expressions of some antioxidant genes in SH-SY5Y cells treated with β-lapachone, morphine and electromagnetic field.
Mahmoudinasab H; Saadat M
Mol Biol Rep; 2018 Jun; 45(3):379-387. PubMed ID: 29611025
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Lai SL; Hwang J; Perng RP; Whang-Peng J
Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
[TBL] [Abstract][Full Text] [Related]
13. Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.
Baek N; Seo OW; Lee J; Hulme J; An SS
Drug Des Devel Ther; 2016; 10():2155-65. PubMed ID: 27445462
[TBL] [Abstract][Full Text] [Related]
14. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
Tanaka T; Masuda H; Naito M; Tamai H
Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).
Husain A; He G; Venkatraman ES; Spriggs DR
Cancer Res; 1998 Mar; 58(6):1120-3. PubMed ID: 9515792
[TBL] [Abstract][Full Text] [Related]
17. Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis.
Villa D; Miloso M; Nicolini G; Rigolio R; Villa A; Cavaletti G; Tredici G
Mol Cancer Ther; 2005 Sep; 4(9):1439-47. PubMed ID: 16170037
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity.
Serinan E; Altun Z; Aktaş S; Çeçen E; Olgun N
J Int Adv Otol; 2018 Aug; 14(2):211-215. PubMed ID: 29460824
[TBL] [Abstract][Full Text] [Related]
19. Sensitizing thermochemotherapy with a PARP1-inhibitor.
Oei AL; Vriend LE; van Leeuwen CM; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJ; Crezee J; Kanaar R; Kok HP; Krawczyk PM; Franken NA
Oncotarget; 2017 Mar; 8(10):16303-16312. PubMed ID: 27557507
[TBL] [Abstract][Full Text] [Related]
20. [Global gene response to GSM 1800 MHz radiofrequency electromagnetic field in MCF-7 cells].
Wang LL; Chen GD; Lu DQ; Chiang H; Xu ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 May; 40(3):159-63. PubMed ID: 16836876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
